Your session is about to expire
← Back to Search
Gastric Bypass Surgery for Type 2 Diabetes
Study Summary
This trial is studying how well gastric bypass surgery works in treating patients with type 2 diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have low hemoglobin levels (less than 11g/dL).I am healthy, have never had surgery, and do not have diabetes.I have myasthenia gravis.I have not developed a serious illness or psychiatric condition recently.I have had gastric bypass surgery and am experiencing severe blockage or diarrhea.I can travel to Cedars-Sinai Medical Center for the study.I have an enlarged prostate.I have type 2 diabetes.I have a brain condition.I have had low blood sugar levels below 50 mg/dl after gastric bypass surgery.My blood pressure or cholesterol levels are not under control.I am unable to understand and agree to the study's details on my own.I have had weight loss surgery and feel no symptoms.I have a history of glaucoma.I am healthy, not planning surgery, and have diabetes.I do not have active heart, lung, liver, GI, or kidney disease.My blood pressure is over 140/90 and I have a history of high cholesterol.I am not on any medication that interacts with atropine, or I can stop it.
- Group 1: Exendin-(9-39)
- Group 2: atropine
- Group 3: GLP-1 and GIP
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research allow geriatric participants?
"This clinical trial requires that participants are within the 18 to 65 age range. For those outside of this demographic, there are 24 studies for minors and 68 trials specifically geared towards elderly patients."
To what ailment are GLP-1 and GIP most often prescribed?
"GLP-1 and GIP are clinically used to reduce cases of uncontrolled lauging, as well as ailments such as rhinorrhoea, pupil constriction, and secretion of bile."
Am I eligible to enroll in this clinical trial?
"To be eligible to partake in this clinical trial, potential participants must have hypoglycemia and fall within the 18-65 age bracket. Additionally, they should be asymptomatic bariatric surgery patients or healthy individuals with no history of diabetes; Lastly, they must also possess enough mobility to come our research centre at Cedars-Sinai Medical Center."
How many volunteers are participating in this clinical experiment?
"Affirmative. Data hosted on clinicaltrials.gov suggests that this medical experiment, initially posted October 1st 2009, is actively searching for participants. 160 individuals need to be enrolled across 2 sites."
What past experiments have utilized GLP-1 and GIP in the study of treatments?
"Currently, 22 clinical trials are investigating GLP-1 and GIP with 6 of these studies in the final Phase 3. Shanghai is hosting some of them but there are 149 global locations engaged in this research effort."
Is there currently an open enrollment period for this trial?
"Clinicaltrials.gov affirms that this medical experiment, initially launched on October 1st 2009, is presently recruiting for participants. The trial details were last revised August 5th 2022."
Share this study with friends
Copy Link
Messenger